Selonterra, a biotechnology company with the aim of discovering therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks, has announced a presentation at the Biotech Showcase™ 2020.

ERS Genomics Limited has signed an agreement with New England Biolabs (NEB®), granting NEB rights to sell CRISPR/Cas9 tools and reagents.

Expedeon shareholders have approved the sale of its proteomics and immunology business, as well as the proposed name change to 4basebio AG, reflecting the Company’s future focus on DNA manufacturing for gene therapy and gene vaccines.

The Pistoia Alliance has announced the publication of a new report into the future of the life science and healthcare industries: ‘2030: Life sciences and Health in the Digital Age’.

AMSBIO has expanded its range of cfPure™ Cell Free DNA Purification Kits for rapid and efficient isolation of circulating cell free DNA (cfDNA).

Until January 15, 2020, researchers up to 35 years, with an advanced degree, who are working in Europe are invited to apply online for the Eppendorf Award for Young European Investigators 2020.

Oxford Gene Technology has developed a targeted NGS panel for constitutional cytogenetics research.

Horizon has announced the addition of predesigned synthetic single guide RNA (sgRNA) to its product range.

In an effort to simplify and accelerate the genomic profiling process, Thermo Fisher Scientific has announced that the Ion Torrent Oncomine Myeloid Research Assay will be available in 2020.

Syngene has announced it is now supplying the AirClean® AC600 Series of PCR Workstations, which use UV irradiation to minimize the risk of airborne DNA contamination.